Natco Pharma shares closed nearly 5% lower after the drugmaker reported a sharp Q1FY27 earnings decline. Consolidated net profit fell 57% to Rs 207 crore, while revenue dropped 44.7% year-on-year to Rs 735 crore.
Natco Pharma shares closed nearly 5% lower after the drugmaker reported a sharp Q1FY27 earnings decline. Consolidated net profit fell 57% to Rs 207 crore, while revenue dropped 44.7% year-on-year to Rs 735 crore.
<iframe src="https://hindustansphere.com/embed/cluster/1a445416dba1ad8260236901c398005e5a1fc7ba" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Natco Pharma Shares End 5% Lower As Q1 Results Spooks Investors; Dividend Declared"></iframe>
